Patent details

93312 Product Name: "Migalastat ou un sel de celui-ci , y compris le sel de chlorhydrate"

Basic Information

Publication number:
93312
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP141687483
Legal Status:
Inactive
Application number:
93312
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1082 - Galafold - migalastat
Marketing Authorization Type:
Marketing Authorization Date:
31/05/2016
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
16/11/2016
First Marketing Authorization date:
31/05/2016
Grant date:
26/01/2017
Activation date:
Publication date:
26/01/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
31/05/2031
SPC Extension Expiration:
31/05/2031
Rejection date:
Withdrawal date:

Owner

From:
16/11/2016
 
 

Name:
Amicus Therapeutics Inc.
Address:
1 Cedar Brook Drive, Cranbury, NJ 08512, United States (US)

Agent

1

Name:
OFFICE FREYLINGER S.A.
From:
26/01/2017
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

2

Name:
OFFICE FREYLINGER S.A.
From:
16/11/2016
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:
26/01/2017

Inventor

1

Name:
Castelli Jeff
Address:
United States (US)

2

Name:
Lockhart David
Address:
United States (US)

Publication

Bulletin

Bulletin Heading:
SPC2
Bulletin edition number:
2017/02
Publication date:
22/06/2017
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/05/2027
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
09/03/2017 Certificate 1
09/03/2017 Publication 1